NDC 61825-999

Orphengesic Forte

Orphenadrine Citrate, Aspirin And Caffeine

Orphengesic Forte is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Galt Pharmaceuticals, Llc. The primary component is Orphenadrine Citrate; Aspirin; Caffeine.

Product ID61825-999_8bdbbced-c8b5-f95b-e053-2a95a90af3d3
NDC61825-999
Product TypeHuman Prescription Drug
Proprietary NameOrphengesic Forte
Generic NameOrphenadrine Citrate, Aspirin And Caffeine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-06-17
Marketing CategoryANDA / ANDA
Application NumberANDA075141
Labeler NameGalt Pharmaceuticals, LLC
Substance NameORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61825-999-60

60 TABLET in 1 BOTTLE, PLASTIC (61825-999-60)
Marketing Start Date2019-06-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61825-999-60 [61825099960]

Orphengesic Forte TABLET
Marketing CategoryANDA
Application NumberANDA075141
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-06-17

Drug Details

Active Ingredients

IngredientStrength
ORPHENADRINE CITRATE50 mg/1

OpenFDA Data

SPL SET ID:8f7380c4-2fec-4799-a883-a4dd91ceba57
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 994539
  • 994535
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]

    NDC Crossover Matching brand name "Orphengesic Forte" or generic name "Orphenadrine Citrate, Aspirin And Caffeine"

    NDCBrand NameGeneric Name
    61825-302ORPHENGESIC FORTEOrphenadrine Citrate, Aspirin and Caffeine
    61825-999Orphengesic ForteOrphenadrine Citrate, Aspirin and Caffeine
    61825-305NorgesicOrphenadrine Citrate, Aspirin and Caffeine
    50991-999Norgesic ForteOrphenadrine Citrate, Aspirin and Caffeine
    21695-726Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    71993-304Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    71993-999Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    74157-999Orphenadrine Citrate, Aspirin and Caffeineorphenadrine citrate, aspirin and caffeine

    Trademark Results [Orphengesic Forte]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ORPHENGESIC FORTE
    ORPHENGESIC FORTE
    73689519 1491921 Dead/Cancelled
    PAR PHARMACEUTICAL, INC.
    1987-10-13

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.